These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 36697236)

  • 1. Development of mRNA Vaccines/Therapeutics and Their Delivery System.
    Son S; Lee K
    Mol Cells; 2023 Jan; 46(1):41-47. PubMed ID: 36697236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [mRNA vaccines for infectious diseases: research progress and applications].
    Qin F; Ren N; Cheng W; Wei H
    Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):3966-3984. PubMed ID: 37877385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in COVID-19 mRNA vaccine development.
    Fang E; Liu X; Li M; Zhang Z; Song L; Zhu B; Wu X; Liu J; Zhao D; Li Y
    Signal Transduct Target Ther; 2022 Mar; 7(1):94. PubMed ID: 35322018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives and Prospects on mRNA Vaccine Development for COVID-19.
    Jin L; Han Z; Zhao P; Sun K
    Curr Med Chem; 2022; 29(23):3991-3996. PubMed ID: 35170403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Development of mRNA Vaccines: Challenges and Opportunities.
    August A; Brito L; Paris R; Zaks T
    Curr Top Microbiol Immunol; 2022; 440():167-186. PubMed ID: 35906319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 mRNA vaccines: Platforms and current developments.
    Szabó GT; Mahiny AJ; Vlatkovic I
    Mol Ther; 2022 May; 30(5):1850-1868. PubMed ID: 35189345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases.
    Rouf NZ; Biswas S; Tarannum N; Oishee LM; Muna MM
    RNA Biol; 2022; 19(1):386-410. PubMed ID: 35354425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Review of mRNA Vaccines.
    Gote V; Bolla PK; Kommineni N; Butreddy A; Nukala PK; Palakurthi SS; Khan W
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36769023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mRNA vaccines for COVID-19: what, why and how.
    Park JW; Lagniton PNP; Liu Y; Xu RH
    Int J Biol Sci; 2021; 17(6):1446-1460. PubMed ID: 33907508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mRNA vaccines for COVID-19 and diverse diseases.
    Hussain A; Yang H; Zhang M; Liu Q; Alotaibi G; Irfan M; He H; Chang J; Liang XJ; Weng Y; Huang Y
    J Control Release; 2022 May; 345():314-333. PubMed ID: 35331783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mRNA-based therapeutics: looking beyond COVID-19 vaccines.
    Parhiz H; Atochina-Vasserman EN; Weissman D
    Lancet; 2024 Mar; 403(10432):1192-1204. PubMed ID: 38461842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in gene-based vaccine platforms to address the COVID-19 pandemic.
    Pushparajah D; Jimenez S; Wong S; Alattas H; Nafissi N; Slavcev RA
    Adv Drug Deliv Rev; 2021 Mar; 170():113-141. PubMed ID: 33422546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications.
    Wang YS; Kumari M; Chen GH; Hong MH; Yuan JP; Tsai JL; Wu HC
    J Biomed Sci; 2023 Oct; 30(1):84. PubMed ID: 37805495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and novel mRNA vaccines in pregnancy: an updated literature review.
    Joubert E; Kekeh AC; Amin CN
    BJOG; 2022 Jan; 129(1):21-28. PubMed ID: 34651406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA vaccines: A transformational advance.
    Brown BD; Fauci AS; Belkaid Y; Merad M
    Immunity; 2023 Dec; 56(12):2665-2669. PubMed ID: 38091944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single Dose SARS-CoV-2 Replicon RNA Vaccine Induces Cellular and Humoral Immune Responses in Simian Immunodeficiency Virus Infected and Uninfected Pigtail Macaques.
    O'Connor MA; Erasmus JH; Randall S; Archer J; Lewis TB; Brown B; Fredericks M; Groenier S; Iwayama N; Ahrens C; Garrison W; Wangari S; Guerriero KA; Fuller DH
    Front Immunol; 2021; 12():800723. PubMed ID: 34992610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities and Challenges for mRNA Delivery Nanoplatforms.
    Zhang Y; Hu Y; Tian H; Chen X
    J Phys Chem Lett; 2022 Feb; 13(5):1314-1322. PubMed ID: 35107010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines.
    Wei J; Hui AM
    Cancer Treat Rev; 2022 Jun; 107():102405. PubMed ID: 35576777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines.
    Zinatizadeh MR; Zarandi PK; Zinatizadeh M; Yousefi MH; Amani J; Rezaei N
    Biomed Pharmacother; 2022 Feb; 146():112527. PubMed ID: 34906769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.